Ameriprise Financial Inc Voyager Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $1.24 Million - $1.7 Million	-123,509 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.05 - $14.21 $226,213 - $399,315	28,101 Added 29.45%	123,509 $1.56 Million
Q1 2020 May 15, 2020	BUY	$6.8 - $14.66 $3,536 - $7,623	520 Added 0.55%	95,408 $873,000
Q4 2019 Feb 14, 2020	BUY	$12.82 - $16.85 $1.22 Million - $1.6 Million	94,888 New	94,888 $1.32 Million

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $206M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.